Thymectomy in 100 prevalent patients with myasthenia gravis
| Thymoma | Non-thymomatous thymectomy | Generalised no thymectomy | Ocular no thymectomy | All patients | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| No | 12 | 12 | 22 | 22 | 41 | 41 | 25 | 25 | 100 | 100 |
| Male | 5 | 42 | 1 | 5 | 14 | 34 | 14 | 56 | 33 | 33 |
| Female | 7 | 58 | 21 | 95 | 27 | 66 | 11 | 44 | 67 | 67 |
| Mean age at presentation | 39.5 | — | 27.2 | — | 51.4 | — | 63.4 | — | 47.5 | — |
| Osserman I | 1 | 8 | 0 | 0 | 0 | 0 | 25 | 100 | 26 | 26 |
| Osserman IIa | 1 | 8 | 1 | 5 | 15 | 37 | 0 | 0 | 17 | 17 |
| Osserman IIb | 3 | 25 | 10 | 45 | 17 | 41 | 0 | 0 | 30 | 30 |
| Osserman III | 5 | 42 | 3 | 14 | 3 | 7 | 0 | 0 | 11 | 11 |
| Osserman IV | 2 | 17 | 8 | 36 | 6 | 15 | 0 | 0 | 16 | 16 |
| Remission (asymptomatic and stable ± treatment) | 4 | 33 | 12 | 55 | 15 | 37 | 14 | 56 | 45 | 45 |
| Remission (asymptomatic and stable off treatment) | 1 | 8 | 6 | 27 | 3 | 7 | 6 | 24 | 16 | 16 |
| Current antiCE | 8 | 67 | 11 | 50 | 32 | 78 | 13 | 52 | 64 | 64 |
| Current steroids | 8 | 67 | 7 | 32 | 19 | 46 | 6 | 24 | 40 | 40 |
| Current azathiaprine | 4 | 33 | 3 | 14 | 3 | 7 | 3 | 12 | 13 | 13 |
| Mean time on immunosupression (y) | 4.4 | — | 3.5 | — | 2.8 | — | 0.8 | — | 3.0 | — |
| Mean No of hospital admissions | 4 | — | 3 | — | 1 | — | 0.8 | — | 1.9 | — |